Update Engelske atlas “mentalhelse”

apps/skde/_posts/helseatlas/en/atlas/mentalhelse.json

@@ -356,7 +356,7 @@
           "utvalg": "Patients receiving outpatient treatment for substance use disorders are defined based on the following criteria: \n\n* Individuals diagnosed with a condition classified under F10, F11, F12, F13, F14, F15, F16, F18, or F19 on Axis 1 (all condition codes) in child and adolescent mental health care services, or those with a primary diagnosis classified under ICD-10 codes starting with F10, F11, F12, F13, F14, F15, F16, F18, or F19 in interdisciplinary specialized addiction treatment, somatic care, rehabilitation, or by publicly funded specialists. \n* Outpatient Treatment is defined as contacts where the patient was admitted and discharged on the same date, irrespective of the reported level of care. This includes both direct and indirect contacts. \n\nAge Group: 18-24 years. \nThe rates are adjusted for age and sex. The lines in the graph represents a 95% confidence interval for the patient rate.",
           "data": "rus18plus_pas_en.json",
           "publisert": "2025-01-31T11:19:00.000Z",
-          "resultat": "Patients aged 18–24 with substance use disorders represent a substantial proportion of those receiving care within child and adolescent mental health services. Annually, approximately 9,000 patients in this group receive outpatient treatment for substance use disorders. The number of patients in treatment increased markedly over the five-year period, with a particularly notable rise following the COVID-19 pandemic. Significant growth in patient rates was observed in areas such as OUS, Helgeland, and Akershus.\n\n\n\nGeographical variation in the patient rate was moderate, with SCV of 6.3 and SCV2 of 5.1. The Norwegian Institute of Public Health’s report, Substance Use Disorders in Norway ([2022](https://www.fhi.no/he/folkehelserapporten/psykisk-helse/rusmiddellidelser/?term=)), suggests that substance use problems are more prevalent in larger urban areas compared to other regions. Given the observed moderate variation and the potential for elevated needs in specific areas, there is insufficient evidence to conclude that the variation in rates is unwarranted.",
+          "resultat": "Patients aged 18–24 with substance use disorders represent a substantial proportion of those receiving care within child and adolescent mental health services. Annually, approximately 4400 patients in this group receive outpatient treatment for substance use disorders. The number of patients in treatment increased markedly over the five-year period, with a particularly notable rise following the COVID-19 pandemic. Significant growth in patient rates was observed in areas such as OUS, Helgeland, and Akershus.\n\nGeographical variation in the patient rate was moderate, with SCV of 6.3 and SCV2 of 5.1. The Norwegian Institute of Public Health’s report, Substance Use Disorders in Norway ([2022](https://www.fhi.no/he/folkehelserapporten/psykisk-helse/rusmiddellidelser/?term=)), suggests that substance use problems are more prevalent in larger urban areas compared to other regions. Given the observed moderate variation and the potential for elevated needs in specific areas, there is insufficient evidence to conclude that the variation in rates is unwarranted.",
           "overskrift": "Patients with Substance Use Disorders Aged 18-24 ",
           "ingress": "\nThere was moderate variation in the patient rate for substance use disorders among individuals aged 18–24 years.",
           "kart": "kart_2024.geojson",
@@ -367,7 +367,7 @@
           "utvalg": "Contact days for substance use disorders are defined based on the following criteria: \n\n* Individuals diagnosed with a condition classified under F10, F11, F12, F13, F14, F15, F16, F18, or F19 on Axis 1 (all condition codes) in child and adolescent mental health care services, or those with a primary diagnosis classified under ICD-10 codes starting with F10, F11, F12, F13, F14, F15, F16, F18, or F19 in interdisciplinary specialized addiction treatment, somatic care, rehabilitation, or by publicly funded specialists. \n* Outpatient Treatment is defined as contacts where the patient was admitted and discharged on the same date, irrespective of the reported level of care. This includes both direct and indirect contacts. Only one contact per day per patient is included. \n\nAge Group: 18-24 years. \nThe rates are adjusted for age and sex.",
           "data": "rus18pluss_konrate_en.json",
           "publisert": "2025-01-31T11:20:00.000Z",
-          "resultat": "Between 2019 and 2023, approximately 9,000 patients aged 18-24 years accounted for 92,000 outpatient contact days for substance use disorder treatment annually. This corresponds to an average of 10.4 contact days per patient per year. While the patient rate increased significantly over this period, the rate of contact days remained stable, indicating that although more patients received treatment, the average number of contact days per patient declined.\n\nSignificant geographical variation was obseved in the rate of outpatient contact days, with SCV of 12.3 and SCV2 of 7.9. For instance, the contact rate in Sørlandet was four times higher than in Førde. Given that the difference in patient rates was approximately half as large, this suggest that the average number of contact days per patient was roughly twice as high in Sørlandet. Referral areas exhibited a range of contact rates distributed between these extremes. According to the Norwegian Institute of Public Health’s report, Substance Use Disorders in Norway ([2022)](https://www.fhi.no/he/folkehelserapporten/psykisk-helse/rusmiddellidelser/?term=), substance use problems are somewhat more prevalent in larger urban areas than in other regions. The observed variation in contact rates is not necessarily unwarranted, as differences in health care needs may justify varying levels of treatment across regions.",
+          "resultat": "Between 2019 and 2023, approximately 4400 patients aged 18-24 years accounted for around 46000 outpatient contact days for substance use disorder treatment annually. This corresponds to an average of 10.4 contact days per patient per year. While the patient rate increased significantly over this period, the rate of contact days remained stable, indicating that although more patients received treatment, the average number of contact days per patient declined.\n\nSignificant geographical variation was obseved in the rate of outpatient contact days, with SCV of 12.3 and SCV2 of 7.9. For instance, the contact rate in Sørlandet was four times higher than in Førde. Given that the difference in patient rates was approximately half as large, this suggest that the average number of contact days per patient was roughly twice as high in Sørlandet. Referral areas exhibited a range of contact rates distributed between these extremes. According to the Norwegian Institute of Public Health’s report, Substance Use Disorders in Norway ([2022)](https://www.fhi.no/he/folkehelserapporten/psykisk-helse/rusmiddellidelser/?term=), substance use problems are somewhat more prevalent in larger urban areas than in other regions. The observed variation in contact rates is not necessarily unwarranted, as differences in health care needs may justify varying levels of treatment across regions.",
           "overskrift": "Outpatient Contact Days for Substance Use Disorders Aged 18-24 ",
           "ingress": "\nThere was substantial variation in the rate of outpatient contact days among individuals aged 18–24 years.",
           "kart": "kart_2024.geojson",